Insider Transactions in Q1 2022 at Artivion, Inc. (AORT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2022
|
Franz Peter Barthold VP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-0.38%
|
$1,520
$20.32 P/Share
|
|
Mar 08
2022
|
Rochelle L. Maney VP, Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
81
-0.41%
|
$1,620
$20.32 P/Share
|
|
Mar 05
2022
|
Franz Peter Barthold VP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
602
-1.46%
|
$12,642
$21.69 P/Share
|
|
Mar 05
2022
|
John E Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,799
-1.01%
|
$37,779
$21.69 P/Share
|
|
Mar 05
2022
|
Jean F Holloway SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,799
-0.88%
|
$37,779
$21.69 P/Share
|
|
Mar 05
2022
|
Amy Horton VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,132
-0.6%
|
$23,772
$21.69 P/Share
|
|
Mar 05
2022
|
David Ashley Lee Executive VP, COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,146
-0.36%
|
$45,066
$21.69 P/Share
|
|
Mar 05
2022
|
James P Mackin President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,029
-1.67%
|
$273,609
$21.69 P/Share
|
|
Mar 05
2022
|
Dennis B Maier SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,090
-1.85%
|
$22,890
$21.69 P/Share
|
|
Feb 27
2022
|
Rochelle L. Maney VP, Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
398
-1.99%
|
$7,562
$19.35 P/Share
|
|
Feb 23
2022
|
Andrew M Green VP Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
5,269
+45.47%
|
-
|
|
Feb 23
2022
|
Franz Peter Barthold VP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+18.8%
|
-
|
|
Feb 23
2022
|
John E Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,623
+8.78%
|
-
|
|
Feb 23
2022
|
Matthew A Getz VP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+20.38%
|
-
|
|
Feb 23
2022
|
Jean F Holloway SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
8,767
+7.84%
|
-
|
|
Feb 23
2022
|
Amy Horton VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+4.83%
|
-
|
|
Feb 23
2022
|
David Ashley Lee Executive VP, COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,437
+3.72%
|
-
|
|
Feb 23
2022
|
James P Mackin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
47,627
+10.82%
|
-
|
|
Feb 23
2022
|
Dennis B Maier SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
7,140
+19.4%
|
-
|
|
Feb 23
2022
|
Rochelle L. Maney VP, Quality |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+19.35%
|
-
|
|
Feb 23
2022
|
Marshall S. Stanton SVP, Clinical & MD Affair |
BUY
Grant, award, or other acquisition
|
Direct |
8,406
+29.86%
|
-
|
|
Feb 19
2022
|
Franz Peter Barthold VP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-2.17%
|
$6,001
$17.75 P/Share
|
|
Feb 19
2022
|
John E Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-0.49%
|
$6,834
$17.75 P/Share
|
|
Feb 19
2022
|
Matthew A Getz VP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
244
-1.72%
|
$4,148
$17.75 P/Share
|
|
Feb 19
2022
|
Jean F Holloway SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
421
-0.44%
|
$7,157
$17.75 P/Share
|
|
Feb 19
2022
|
Amy Horton VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
256
-0.28%
|
$4,352
$17.75 P/Share
|
|
Feb 19
2022
|
David Ashley Lee Executive VP, COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
526
-0.18%
|
$8,942
$17.75 P/Share
|
|
Feb 19
2022
|
James P Mackin President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,204
-0.92%
|
$54,468
$17.75 P/Share
|
|
Feb 19
2022
|
Dennis B Maier SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-1.24%
|
$4,794
$17.75 P/Share
|
|
Feb 17
2022
|
Franz Peter Barthold VP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,757
-5.3%
|
$29,869
$17.5 P/Share
|
|
Feb 17
2022
|
Franz Peter Barthold VP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
5,883
+14.98%
|
-
|
|
Feb 17
2022
|
Andrew M Green VP Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
576
-35.4%
|
$9,792
$17.5 P/Share
|
|
Feb 17
2022
|
Andrew M Green VP Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
1,627
+50.0%
|
-
|
|
Feb 17
2022
|
John E Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,035
-1.25%
|
$34,595
$17.5 P/Share
|
|
Feb 17
2022
|
John E Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,797
+5.67%
|
-
|
|
Feb 17
2022
|
Matthew A Getz VP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,428
-5.03%
|
$24,276
$17.5 P/Share
|
|
Feb 17
2022
|
Matthew A Getz VP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
6,079
+17.45%
|
-
|
|
Feb 17
2022
|
Jean F Holloway SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,579
-1.24%
|
$60,843
$17.5 P/Share
|
|
Feb 17
2022
|
Jean F Holloway SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
10,669
+5.24%
|
-
|
|
Feb 17
2022
|
Amy Horton VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,418
-0.79%
|
$24,106
$17.5 P/Share
|
|
Feb 17
2022
|
Amy Horton VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,079
+3.26%
|
-
|
|
Feb 17
2022
|
David Ashley Lee Executive VP, COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,514
-0.44%
|
$42,738
$17.5 P/Share
|
|
Feb 17
2022
|
David Ashley Lee Executive VP, COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
12,547
+2.15%
|
-
|
|
Feb 17
2022
|
James P Mackin President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,133
-2.32%
|
$274,261
$17.5 P/Share
|
|
Feb 17
2022
|
James P Mackin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
60,242
+7.96%
|
-
|
|
Feb 17
2022
|
Dennis B Maier SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,463
-3.2%
|
$24,871
$17.5 P/Share
|
|
Feb 17
2022
|
Dennis B Maier SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
6,275
+11.97%
|
-
|
|
Feb 17
2022
|
Rochelle L. Maney VP, Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
979
-3.22%
|
$16,643
$17.5 P/Share
|
|
Feb 17
2022
|
Rochelle L. Maney VP, Quality |
BUY
Grant, award, or other acquisition
|
Direct |
1,627
+9.36%
|
-
|
|
Feb 17
2022
|
Marshall S. Stanton SVP, Clinical & MD Affair |
SELL
Payment of exercise price or tax liability
|
Direct |
772
-6.37%
|
$13,124
$17.5 P/Share
|